272 related articles for article (PubMed ID: 19291092)
1. The context of tetanus toxoid application influences the outcome of antigen-specific and self-directed humoral immune response.
Stojanović M; Zivković I; Inić-Kanada A; Petrusić V; Mićić M; Dimitrijević L
Microbiol Immunol; 2009 Feb; 53(2):89-100. PubMed ID: 19291092
[TBL] [Abstract][Full Text] [Related]
2. Induction of decreased fecundity by tetanus toxoid hyper-immunization in C57BL/6 mice depends on the applied adjuvant.
Zivkovic I; Petrusic V; Stojanovic M; Inic-Kanada A; Stojicevic I; Dimitrijevic L
Innate Immun; 2012 Apr; 18(2):333-42. PubMed ID: 21926163
[TBL] [Abstract][Full Text] [Related]
3. Vaccine model of antiphospholipid syndrome induced by tetanus vaccine.
Dimitrijević L; Živković I; Stojanović M; Petrušić V; Živančević-Simonović S
Lupus; 2012 Feb; 21(2):195-202. PubMed ID: 22235053
[TBL] [Abstract][Full Text] [Related]
4. Induction of APS after TTd hyper-immunization has a different outcome in BALB/c and C57BL/6 mice.
Zivkovic I; Stojanovic M; Petrusic V; Inic-Kanada A; Dimitrijevic L
Am J Reprod Immunol; 2011 May; 65(5):492-502. PubMed ID: 21029246
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant dependence of APS pathology-related low-affinity antibodies during secondary immune response to tetanus toxoid in BALB/c mice.
Zivković I; Petrušić V; Dimitrijević R; Stojanović M; Dimitrijević L
Immunol Res; 2013 May; 56(1):143-9. PubMed ID: 23161337
[TBL] [Abstract][Full Text] [Related]
6. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity.
Bondanza A; Zimmermann VS; Dell'Antonio G; Cin ED; Balestrieri G; Tincani A; Amoura Z; Piette JC; Sabbadini MG; Rovere-Querini P; Manfredi AA
Arthritis Rheum; 2004 May; 50(5):1549-60. PubMed ID: 15146425
[TBL] [Abstract][Full Text] [Related]
7. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
8. Network connectivity is shown to change in C57BL/6 mice during a continuing immune response subsequent to tetanus toxoid hyperimmunization.
Zivkovic IP; Stojanovic MM; Petrusic VZ; Inic-Kanada AB; Micic MV; Dimitrijevic LA
Biol Res; 2010; 43(4):393-402. PubMed ID: 21526265
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of tetanus toxoid-specific immune responses by a traditional Chinese herbal medicine.
Underwood JR; Chivers M; Dang TT; Licciardi PV
Vaccine; 2009 Nov; 27(47):6634-41. PubMed ID: 19781825
[TBL] [Abstract][Full Text] [Related]
10. Murine monoclonal antibody 26 raised against tetanus toxoid cross-reacts with beta2-glycoprotein I: its characteristics and role in molecular mimicry.
Inic-Kanada A; Stojanovic M; Zivkovic I; Kosec D; Micic M; Petrusic V; Zivancevic-Simonovic S; Dimitrijevic L
Am J Reprod Immunol; 2009 Jan; 61(1):39-51. PubMed ID: 19086991
[TBL] [Abstract][Full Text] [Related]
11. Role of molecular mimicry and polyclonal cell activation in the induction of pathogenic β2-glycoprotein I-directed immune response in Balb/c mice upon hyperimmunization with tetanus toxoid.
Stojanović M; Petrušić V; Zivković I; Inić-Kanada A; Stojićević I; Marinković E; Dimitrijević L
Immunol Res; 2013 May; 56(1):20-31. PubMed ID: 22875539
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody response and pregnancy-related pathology induced by combined LPS and tetanus toxoid hyperimmunization in BALB/c and C57BL/6 mice.
Petrušić V; Todorović N; Živković I; Dimitrijević R; Muhandes L; Rajnpreht I; Dimitrijević L
Autoimmunity; 2015 Mar; 48(2):87-99. PubMed ID: 25430703
[TBL] [Abstract][Full Text] [Related]
13. Immunization of naive BALB/c mice with human beta2-glycoprotein I breaks tolerance to the murine molecule.
Tincani A; Gilburd B; Abu-Shakra M; Blank M; Allegri F; Ottaviani R; Riboni M; Meroni PL; Balestrieri G; Shoenfeld Y
Arthritis Rheum; 2002 May; 46(5):1399-404. PubMed ID: 12115248
[TBL] [Abstract][Full Text] [Related]
14. Suramin has adjuvant properties and promotes expansion of antigen-specific Th1 and Th2 cells in vivo.
Denkinger M; Shive CL; Pantenburg B; Forsthuber TG
Int Immunopharmacol; 2004 Jan; 4(1):15-24. PubMed ID: 14975356
[TBL] [Abstract][Full Text] [Related]
15. Conjugation of protein antigen to microparticulate beta-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations.
Berner VK; Sura ME; Hunter KW
Appl Microbiol Biotechnol; 2008 Oct; 80(6):1053-61. PubMed ID: 18677470
[TBL] [Abstract][Full Text] [Related]
16. The ocular conjunctiva as a mucosal immunization route: a profile of the immune response to the model antigen tetanus toxoid.
Barisani-Asenbauer T; Inic-Kanada A; Belij S; Marinkovic E; Stojicevic I; Montanaro J; Stein E; Bintner N; Stojanovic M
PLoS One; 2013; 8(4):e60682. PubMed ID: 23637758
[TBL] [Abstract][Full Text] [Related]
17. Low-frequency ultrasound as a transcutaneous immunization adjuvant.
Tezel A; Paliwal S; Shen Z; Mitragotri S
Vaccine; 2005 May; 23(29):3800-7. PubMed ID: 15893617
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant properties of bacterial product cantastim.
Anghelache IF; Caras I; Salageanu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):17-21. PubMed ID: 18928058
[TBL] [Abstract][Full Text] [Related]
19. A predictive equation for the primary immune response of mice to adsorbed tetanus toxoid as a function of dose of antigen and dose of adjuvant.
Levine L
J Immunol; 1972 Nov; 109(5):1338-42. PubMed ID: 5079094
[No Abstract] [Full Text] [Related]
20. Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15.
Carvalho LV; Ruiz Rde C; Scaramuzzi K; Marengo EB; Matos JR; Tambourgi DV; Fantini MC; Sant'Anna OA
Vaccine; 2010 Nov; 28(50):7829-36. PubMed ID: 20937318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
